The IPO of PACS Group, Inc represents a significant event for the company, introducing it to the public market. The pricing of shares between $20.00 and $22.00 indicates a strong entry point, and the focus on post-acute healthcare, a critical and growing sector, suggests potential for growth. The insider lock-up period ending on October 08, 2024, also indicates a commitment from insiders to the company's future, potentially stabilizing the stock in the short term.